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Abstract: A functional polymorphism of the gene coding for Catechol-O-methyltrasferase
(COMT), an enzyme responsible for the degradation of the catecholamine dopamine (DA),
epinephrine, and norepinephrine, is associated with cognitive deﬁcits. However, previous studies
have not examined the effects of COMT on context processing, as measured by the AX-CPT,
a task hypothesized to be maximally relevant to DA function. 32 individuals who were either
healthy, with schizotypal personality disorder, or non-cluster A, personality disorder (OPD)
were genotyped at the COMT Val158Met locus. Met/Met (n = 6), Val/Met (n = 10), Val/Val
(n = 16) individuals were administered a neuropsychological battery, including the AX-CPT
and the N-back working memory test. For the AX-CPT, Met/Met demonstrated more AY errors
(reﬂecting good maintenance of context) than the other genotypes, who showed equivalent error
rates. Val/Val demonstrated disproportionately greater deterioration with increased task difﬁculty
from 0-back to 1-back working memory demands as compared to Met/Met, while Val/Met did not
differ from either genotypes. No differences were found on processing speed or verbal working
memory. Both context processing and working memory appear related to COMT genotype and
the AX-CPT and N-back may be most sensitive to the effects of COMT variation.
Keywords: COMT, dopamine, context processing, working memory, schizotypal personality
disorder

Catecholamine neurotransmitter activity in the prefrontal cortex (PFC) exerts an inﬂuence over a range of cognitive functions. Speciﬁcally, catechol-O-methyltransferase
(COMT) is an important enzyme involved in the regulation of catecholamines,
including dopamine (DA). A single nucleotide polymorphism of the gene coding
for COMT is associated with performance with working memory (Goldberg et
al 2003) and executive functions in schizophrenia (Egan et al 2001; Joober et al
2002), with Val allele associated with increased enzymatic activity (leading to more
catabolism of DA) and resultant poorer cognitive performance. In a recent study,
Minzenberg et al (2006) demonstrated similar effects of the COMT genotype on
cognitive performance in patients with schizotypal personality disorder (SPD). It is
of interest that patients with SPD have been shown previously to manifest substantial abnormalities on tasks highly dependent on the functioning of the prefrontal
cortex (PFC), including the ability to maintain contextual information in short term
memory (Barch et al 2004).
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Context processing, defined as information actively
maintained in such a form that it can be used to mediate
later last-appropriate behavior, is particularly relevant in
two ways. First, it has been suggested that a speciﬁc deﬁcit
in the ability to represent and maintain context information
may help to explain deﬁcits in working memory as well as
other cognitive domains in schizophrenia and the spectrum
disorders (Cohen and Servan-Schreiber 1992; Cohen et al
1999). In a neuroimaging study (Barch et al 2001), working
memory deﬁcits in patients with schizophrenia was shown
to reﬂect impairment in context processing associated with
a selective disturbance in dorsolateral PFC functions.
Second, context processing has been directly linked to DA
function, in that D-amphetamine (D-AMP), a DA agonist,
results in improved context processing (Servan-Schreiber
et al 1998). Recent evidence from a double-blind, placebocontrolled trial of guanfacine treatment suggest that not only do
patients with SPD perform more poorly on a context processing
task than healthy control and patients with non-schizotypal
personality disorders, pharmacological compounds increasing
catecholamine activity in PFC exert a normalizing inﬂuence
on context processing in SPD patients (McClure et al in press).
Given its dopaminergic relevance, impaired context processing may also be related to the effects of the COMT genotype.
However, there are no published data available on the relationship between COMT and context processing to date.
Tasks that measures executive functioning, such as the
Wisconsin Card Sorting Test (WCST) (Egan et al 2001;
Joober et al 2002; Malhotra et al 2002; Minzenberg et al 2006)
and working memory, such as the N-back test (Goldberg et al
2003), and, by inference, the functioning of the dorsolateral
PFC, have been shown to be related to the COMT genotype
in healthy and schizophrenic individuals in some studies.
Interestingly, Mattay et al (2003) reported better performance
in carriers of the Val allele and a decline in the Met/Met
group in a working memory task after a pharmacological
challenge with amphetamine. The decline in performance
in the Met/Met group after amphetamine intake suggests
that the association between performance and DA levels has
an inverted “U” shape characteristic. That is, activation of
the DA system by working memory load and amphetamine
pushes these subjects beyond their optimal activation level.
However, other investigators did not ﬁnd support that these
tasks, presumed to be dopaminergic-depended tasks, were
associated to COMT genotype (Tsai et al 2003; Ho et al
2005; Minzenberg et al 2006). Speciﬁcally, performance on
measures like the WCST, digit span backward subtest of the
WAIS-III, N-back test, and Trail Making (Ho et al 2005) were
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not associated with COMT genotype in healthy individuals or
patients with schizophrenia. Additionally, COMT genotype
did not exert an effect on tasks measuring verbal or visual
delayed memory in healthy and schizotypal personality
disorder individuals (Minzenberg et al 2006).
The AX Continuous Performance Test (AX-CPT)
(Barch et al 2004) is a task speciﬁcally designed to assess
context processing. During the AX-CPT, participants are
presented with cue-probe pairs and are told to respond to
an “X” (probe), but only when it follows an “A” (cue).
The task also includes three types of non-target trials that
allow one to selectively assess context processing deﬁcits:
AY trials (“A” cue followed by any letter other than “X”);
BX trials (non-“A” cue followed by an “X” probe); and BY
trials (non-“A” cue followed by a non-“X” probe). AX trials
occur with high frequency (70%), creating two important
response biases. First, this high AX frequency creates a bias
to make a target response to any stimulus following an “A”
cue (as a target “X” occurrence is highly likely following an
“A” cue). In healthy individuals, maintenance of context is
demonstrated by the tendency to make a false alarm response
after occurrence of the “A” cue when not followed by an “X”
(leading to increased AY errors). Conversely, low levels of
AY errors suggest reduced tendencies toward development of
context representations. The second bias created by the high
AX frequency is the tendency to make a target response to
the “X” probe, as this is the correct response the majority of
the time. On BX trials, maintenance of the context provided
by the cue (non-A) reduces BX false alarms. Thus, on the
AX-CPT, deﬁcits in context processing are not indicated
by an overall increase in false alarms, but rather a speciﬁc
pattern of errors (decreased AY and increased BX).
In light of the current mixed ﬁndings regarding the
association between DA-dependent tasks and the effects
of COMT genotype, it is unclear whether COMT exerts
a general effect on poor neurocognitive functioning or a
speciﬁc deﬁcit in one cognitive domain. Given the direct
link to DA function and the PFC, the current study sought
to examine whether COMT genotype variation has a speciﬁc
impact on context processing. The Modiﬁed AX-CPT is the
prototypical context processing task and is hypothetically one
of the cognitive domains that is most DA relevant, and we
hypothesized that it may be the most relevant task that is sensitive to the COMT effects, as compared to other DA-related
tasks, including the N-back, measuring working memory,
Trail Making, measuring processing speed and attention, and
the Paced Auditory Serial Addition Test (PASAT) (Gronwall
1977), measuring maintenance and manipulation processes in
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verbal working memory. Previous studies have demonstrated
that a functional genetic polymorphism of COMT inﬂuences
prefrontal cognition in healthy individuals (Bruder et al 2005;
Egan et al 2001; Malhotra et al 2002), healthy siblings of
patients with schizophrenia spectrum disorders (Rosa et al
2004), and patients with schizophrenia (Egan et al 2001). Further, one published study reported that poorer performance
on prefrontal-dependent tasks is associated with the Val/Val
genotype regardless of diagnosis in a group of healthy individuals and patients with SPD and OPD (Minzenberg et al
2006). Thus, in our ongoing study, we examined the shared
effects of COMT variation on cognition in individuals with
and without schizophrenia spectrum disorders, with the
focus of examining tests hypothesized to be most sensitive to
dopaminergic functions. As such, genotyping was collapsed
across healthy individuals, patients with SPD, and patients
with other, non-cluster A personality disorders (OPDs).
We predicted that subjects with the Val allele would show
impairment in context processing, as evidence by a greater
number of BX errors and a smaller number of AY errors on
the AX-CPT, while subjects in the Met/Met group would
demonstrate an inverse response pattern with a greater number AY errors and a smaller number of BX errors, reﬂecting
intact context processing. We also predicted that, compared to
the Met/Met group, subjects with the Val allele would show
impaired working memory as measured by the N-back. In
addition to evaluating N-back accuracy score at each condition
with different levels of difﬁculty, we propose that examining
the degree of improvement that takes place from one condition to the following condition with increased difﬁculty would
allow us to better understand working memory deﬁcit as it
relates to COMT. We predicted that subjects with the Val allele
would perform disproportionately worse as the task increases
demands of working memory in comparison to the Met/Met
group. Further, we predict that group differences in AX-CPT
performance would yield a greater effect size, as compared to
the N-back, suggesting that the AX-CPT is a more sensitive
test to detect the effects on DA exerted by COMT.

Methods
Participants
As part of a larger study examining context processing
in schizotypal personality disorder, 11 individuals with
Diagnostic and Statistical Manual of Mental Disorders, 4th
Edition (DSM-IV; American Psychiatric Association, 1994)
SPD, two individuals with other, non-cluster A, DSM-IV
personality disorders (OPD) and 19 healthy controls (HCs)
were genotyped and evaluated on context processing and
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working memory. Participants with SPD and OPD were
ascertained either through recruitment from the outpatient
clinics at the Mount Sinai Medical Center and Bronx Veteran
Affairs Medical Center, by advertisements in local newspapers,
or by referral from psychiatrists and psychologists in the local
community. The HCs were recruited from the local community through newspaper advertisements. Participants were
excluded for (a) meeting criteria for current (within six months
of testing) substance abuse or dependence, (b) a positive urine
toxicology screen, (c) a lifetime diagnosis of a psychotic
disorder or bipolar I disorder and (d) signiﬁcant head trauma.
Participants were assessed for Axis I psychopathology using
the Structured Clinical Interview for DSM-IV (SCID; First et
al 1995), by a master’s level or doctoral level interviewer who
did not know the participants’ cognitive task performance.
In addition, participants were assessed for Axis II pathology
using the Structured Interview for the DSM-IV Personality
Disorders (SIDP; Pfohl et al 1995). Consensus diagnoses were
reached in a meeting of all raters with an expert diagnostician.
OPD individuals were excluded from the current analyses if
they met criteria for any Cluster A personality disorder (ie,
paranoid personality disorder, schizoid personality disorder or
if they met more than two criteria for SPD. Healthy controls
were excluded if they had either a personal or family history
of a major Axis I disorder (eg, schizophrenia), or a personal
history of an Axis II disorder. All participants signed informed
consent forms in accordance with the approvals of Institutional
Review Boards at each research site, where ethical approval
for the study procedures was obtained.

Tasks and apparatus
AX-CPT tasks
Participants performed the modiﬁed version of the AX-CPT,
in which sequences of letters were visually presented one at a
time in a continuous fashion on a computer display. Subjects
were instructed to identify target and non-target trials with a
button press using separate ﬁngers on the same hand. Target
trials were deﬁned as a cue-probe sequence, in which the
letter “A” appeared as the cue, and the letter “X” appeared
as the probe. The remaining letters of the alphabet served
as invalid cues (ie, cues that were not A’s) and non-target
probes (ie, probes that were not X’s), with the exception of
the letters K and Y, which were excluded due to their similarity in appearance to the letter X. Letter sequences were
presented in pseudorandom order, such that target (AX) trials
occurred with 70% frequency, and non-target trials occurred
with 30% frequency. Non-targets were divided evenly (10%
each) among the following trial types: BX trials, in which
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an invalid cue (ie, non-A) preceded the target; AY trials,
in which a valid cue was followed by a non-target probe
(ie, non-X); and BY trials, in which an invalid cue was followed by a non-target probe. The delay between cue and
probe was manipulated so that half of the trials had a short
delay and half had a long delay. On short delay trials, the
cue-probe interval was 1 sec, and the inter-trial interval was
4900 msec. On long delay trials, the cue-probe interval was
5 sec and the inter-trial interval was 1 sec. Thus, the total
trial duration was equivalent across conditions, providing
a means of controlling for general factors that might affect
performance (eg, pace of the task, response frequency, total
time on task). The task was presented in 4 blocks of 50 trials,
all of which were either short (2 blocks) or long (2 blocks)
delay trials, with the order of short and long delay blocks
counterbalanced across subjects.
Stimuli were presented centrally, for a duration of
300 msec, in 24-point uppercase Helvetica font. Subjects
were instructed to respond to both cue and probe stimuli,
pressing one button for targets and another button for
non-targets (cues were always considered non-targets).
Responses were recorded on a specially constructed button
box connected to the computer that recorded response choice
and reaction time with 1 msec accuracy. For right-handed
individuals, responses were made with the middle (nontarget, middle button) and index (target, right button) ﬁngers
of the right hand. For left-handed individuals, responses
were made with the middle (non-target, middle button) and
index (target, right button) ﬁngers of the left hand. Following
previous work (Barch et al 2004), subjects were allowed a
total of 1300 msec from stimulus onset in which to respond.
Responses slower than this limit were not recorded, and
elicited feedback (a “bloop” sound) as a prompt to increase
speed. The task was run on Apple Macintosh computers,
using PsyScope software for stimulus presentation and data
collection (Cohen et al 1993).

participants observed letters presented on a computer screen
one at a time. There were three conditions: (1) 0-back, (2)
1-back, and (3) 2-back. In the 0-back condition, participants
responded to a single pre-speciﬁed target letter (eg, X). In
the 1-back condition, the target was any letter identical to
the one immediately preceding it (ie, one trial back). In the
2-back condition, the target was any letter identical to the
one presented 2 trials back. Thus, working memory load
is increased incrementally from the 0-back to the 2-back
conditions.
Stimuli were presented as single letters appearing
centrally in 24-point Helvetica font, white against a black
background, subtending a visual angle of approximately
3 degrees. All consonants of the alphabet were used as stimuli
with the exception of L (because it is easily confused with
the number “1”) and W (because it is the only two syllable
letter of the alphabet). Vowels were excluded. Further, the
case of the presented lettered-stimuli changed randomly
throughout the trials. Stimuli were presented in a pseudorandom sequence of consonants, randomly varying in case
in order to prevent participants from relying on strategies of
perceptual familiarity for responding. Stimuli were presented
centrally on a controlled computer display for 500 msec. The
inter-stimulus interval (ISI) was 2500 msec. Targets were
presented on 33% of the trials. Conditions were presented
in blocks of 25 trials, with three blocks at each load level
(0-, 1-, 2-back) presented in a counterbalanced order. The ISI
and target density for the N-back test were selected in order
to be consistent with prior studies using this test (Casey et al
1995; Cohen et al 1996; Braver et al 1997).

WAIS-III vocabulary and block design
The Vocabulary and Block Design subtests of the WAIS-III
(Wechsler, 1997) are the best correlates of overall IQ (Tulsky
et al 1997; Wechsler 1997). These subtests were administered to obtain an estimate of general level of intellectual
ability.

N-back working memory task
The N-back is a commonly used measure of working memory
(Braver et al 1997; Casey et al 1995; Cohen et al 1996) that
has been frequently shown to elicit performance deﬁcits
among individuals with schizophrenia and their unaffected
relatives (Callicott et al 2000; Egan et al 2001; Menon et al
2001; Perlstein et al 2001; Barch et al 2002; Callicott et al
2003). The N-back test manipulates complexity with working
memory load, rather than retention duration or interference
conditions. Materials for the N-back task were similar to
those used by Braver et al (1997). In the current study,
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Other neuropsychological measures
Trail Making Part A and B (Reitan and Wolfson, 1993) is a
timed test that measures processing and psychomotor speed.
On part A, subjects are presented with numbers from one
to 25 randomly placed on a sheet of paper and instructed
to connect the numbers in their correct numerical order as
quickly as possible. Part B is analogous to Part A with the
addition of letters and subjects are instructed to alternate
between numbers and letters in numerical and alphabetical
order. The PASAT (Gronwall 1977) measures maintenance
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and manipulation processes in verbal working memory. On
this test, subjects listen to a tape recorded voice presenting a
series of numbers and are asked to add each adjacent pair of
numbers and respond by verbalizing the sum. There are 50
trials at a rate of one digit per two seconds, with total correct
detections as the dependent variable.
Participants were tested in a single testing session. Task
order was counterbalanced across participants. Prior to
performance of the ﬁrst block of each computerized task,
standardized instructions describing the task appeared
on the computer, and the experimenter answered any
remaining questions regarding them. Participants were
asked to respond as quickly as possible to each stimulus
while maintaining accuracy. One full block of trials was
then performed as practice prior to administration of the
experimental trials for that condition. This ensured that
subjects understood the instructions and were performing
the task appropriately.

COMT genotyping
Blood samples were collected from all participants and DNA
was extracted. COMT Val108/158Met (rs4680) genotype
was determined as a restriction fragment length polymorphism after polymerase chain reaction (PCR) ampliﬁcation from genomic DNA. DNA sequences were obtained
from GenBank (accession no: Z26491). The sequence
of primers and probes were as follows: forward primer,
5′-TCGAGATCAACCCCGACTGT-3′; reserve primer,
5′-AACGGGTCAGGCATGCA-3′; probe for Val allele,
5′-6FAM-CCTTGTCCTTCACGCCAGCGA-3′-TAMRA;
and probe for Met allele, 5′-VIC-ACCTTGTCCTTCATGCCAGCGA-3′-TAMRA. The genotyping protocol has
been described elsewhere (Xu et al 2002; Minzenberg
et al 2006). Brieﬂy, individual genotyping was measured
by using Applied Biosystems (ABI; Foster City, California,
USA) 7900 Sequence Detector with a 5 μl reaction volume
and 1–3 mg DNA. Primer concentration was 900 nmol/l for
each primer and 100 nmol/l concentration for each probe.
Annealing temperature was 63.5 °C with 35 cycles. Genotyping was clustered by using SDS 2.2 software (ABI). Each
cluster represented homozygous Val allele, heterozygous
Val/Met, Homozygous Met/Met allele and no DNA template
control.

Data analysis
Participants were collapsed diagnostic groups for genotyping and analyses were conducted with group comparison between the different COMT genotypes for two
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reasons. First, polymorphism of COMT also influences
prefrontal cognition in healthy individuals as well as
schizophrenia patients, and performance on prefrontaldependent tasks is associated with the Val/Val genotype
regardless of diagnosis. Second, the focus of the paper is
to investigate the association between COMT and a task
(ie, AX-CPT) hypothesized to be maximally relevant
to DA function. For the AX-CPT, analyses focused on
error rates for the two error types most related to effective context processing, BX and AY, for both the short
and long delay intervals. Context processing data were
analyzed using analyses of variance (ANOVAs) with
genotype as a between-subject factor and trial type and
delay as within-subject factors. For the N-back, accuracy scores were calculated for each participant across
the three conditions (0-back, 1-back, 2-back). ANOVAs
were conducted to examine the accuracy responses from
the N-back with genotype as a between-subject factor
and condition as a within-subject factor. Additionally,
change scores were calculated to capture changes in performance as the N-back test increased in difficulty from 0
to 1-back and 1 to 2-back. While accuracy scores provide
information on performance level at each task condition,
change scores would yield additional information regarding the proportion of worsening as load increased in the
task Greater changes indicate greater vulnerability to
increases in processing demands. A series of Univariate
ANOVAs were conducted to examine changes in performance with genotype as the between-subject factor and
change scores as the dependent variable. For all posthoc
analyses, planned contrasts were conducted for multiple
pairwise comparisons and Bonferroni was used to adjust
for the alpha level.

Results
Demographic information
Three groups of COMT genotypes were identiﬁed, including Met/Met (n = 6), Val/Met (n = 10) and Val/Val (n = 16).
Demographic characteristics of the genotype groups are
shown in Table 1. One participant has missing demographic
data. The genotypes did not differ on age, F(2, 28) = 0.60,
p = 0.56, education, F(2, 28) = 0.56, p = 0.58, ethnicity,
χ2(8) = 7.55, p = 0.48, gender composition, χ2(2) = 0.02,
p = 0.99, or estimated IQ as measured by WAIS Vocabulary,
F(2, 28) = 0.65, p = 0.53 or Block Design, F(2, 27) = 1.20,
p = 0.32. The majority of the participants (84.4%) were righthanded individuals, but again, the genotypes did not differ
on handedness, χ2(2) = 1.40, p = 0.50.
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Table 1 Sample characteristics
Group
Met/Met

Val/Met

Val/Val

M

SD

M

SD

M

SD

Age (in years)
Sex (% male)
Handedness (% right)

31.7
66.7
100

10.7
-

31.0
70.0
88.9

11.4
-

35.8
68.8
81.3

10.8
-

Education (in years)
Vocabulary scores
Block design scores

16.1
9.8
12.0

2.6
2.4
3.0

16.7
10.2
12.7

4.1
2.7
3.7

15.1
11.13
10.6

3.7
2.6
3.1

Effects of COMT genotype on context
processing
For the purposes of this study, we will focus on main effects
of genotype or interaction with genotype in all of the analyses
presented below, as our hypotheses focused on genotypic
differences. The error data from the AX-CPT was analyzed
using a 3-factor ANOVA, with genotype (Met/Met, Val/Met,
Val/Val) as a between-subject factor, and both delay (short,
long) and error type (AX, AY, BX, BY) as within-subject
factors. Descriptive statistics for the AX-CPT are presented
in Table 2. The ANOVA did not reveal a signiﬁcant main
effect of genotype, F(2, 29) = 0.54, p = 0.59. However, there
was a non-signiﬁcant trend for an error type by genotype
interaction, F(6, 56) = 2.06, p = 0.07, with the Val/Val group
making more BX than AY errors, while the Val/Met and
Met/Met groups made more AY and BX errors. Given our
small sample sizes, we followed up the interaction although
it was nonsigniﬁcant.
Follow up univariate ANOVAs showed a signiﬁcant
genotype difference in AY errors during the short delay
condition, F(2, 29) = 3.77, p  0.05, R2 = 0.21. Compared to
Met/Met, Val/Met (p  0.05) and Val/Val (p 0.05) made
Table 2 Standard AX-CPT errors
Group
Error type
Short delay
AX
AY
BX
BY
Long delay
AX
AY
BX
BY

Met/Met

Val/Met

Val/Val

M (SD)

M (SD)

M (SD)

3.8 (6.5)
20.0 (26.8)
3.3 (5.2)
1.7 (4.1)

1.4 (1.5)
4.0 (7.0)
5.3 (7.7)
2.3 (4.8)

1.6 (3.3)
4.4 (6.4)
7.5 (25.2)
2.0 (4.4

20.1 (25.9)
16.7 (24.2)
3.5 (5.5)
0.0 (0.0)

7.6 (11.6)
11.2 (11.2)
11.4 (15.5)
0.0 (0.0)

11.8 (20.0)
1.9 (5.4)
13.3 (25.5)
1.4 (5.6)

Note: Error data are proportions of errors.
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signiﬁcantly fewer AY errors, but Val/Met and Val/Val did
not differ. Similarly, there was also a signiﬁcant genotype
difference in AY errors during the long delay F(2, 29) =
3.69), p  0.05, R2 = 0.20, with Met/Met making more AY
errors compare to the Val/Val (p  0.05) while the Val/Met
did not differ from the other two groups (p  0.05). There
were no genotype differences in BX errors during the short
F(2, 29) = 0.12, p = 0.89, or long F(2, 29) = 0.51, p = 0.61
delay. These results suggest that although the groups did not
differ on BX false alarms, Met/Met subjects demonstrated
better maintenance of context relative to Val/Met and Met/
Met subjects, as reﬂected by the AY errors.

Effects of COMT genotype on working
memory
The accuracy data from the N-back were analyzed using a 2factor ANOVA with genotype (Met/Met, Val/Met, Val/Val)
as a between subject factor and condition (0-back, 1-back,
2-back) as a within-subject factor. A signiﬁcant main effect
of condition was found, F(2, 28) = 8.21, p  0.01, but there
was no signiﬁcant main effect of genotype, F(2, 29) = 0.61,
p = 0.55, or interaction, F(4, 58) = 1.74, p = 0.15. As displayed on Table 3, participants performed the worst at 2-back
compared to the other two conditions (p’s  0.01), though
there were no differences in performance between 0-back
and 1-back (p 0.05).
Genotype comparison analyses were conducted to examine changes in performance as the task increased in difﬁculty
(ie, the difference in accuracy score from one condition to
another). This mechanism would provide more meaning
information on differential deterioration as the task becomes
more demanding. Change scores were calculated to capture
changes in performance from 0-back to 1-back, 1-back to
2-back, and 0-back to 2-back. The ANOVA revealed a signiﬁcant genotype difference in performance from 0-back to
1-back, F(2, 29) = 3.66, p0.05), R2 = 0.20. As shown in
Figure 1, Val/Val subjects had a greater change score compared to Met/Met subjects (p 0.05), suggesting a greater

Table 3 N-back working memory accuracy scores
Group
Met/Met
0-back
1-back
2-back

Val/Met

Val/Val

M (SD)

M (SD)

M (SD)

88.9 (11.0)
92.5 (8.6)
86.4 (5.2)

94.7 (5.8)
92.7 (5.9)
88.0 (12.1)

97.9 (1.6)
92.8 (6.4)
86.7 (9.6)

Note: Response data are proportion of correct responses.
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0.16
0.14
0.12
0.1
0.08
0.06

Met/Met

0.04

Val/Met
Val/Val

0.02
0
–0.02

0- to 1-back*

1- to 2-back

0- to 2-back

–0.04
–0.06
–0.08

Figure 1 Proportions of change in performance on the n-back test as captured by difference scores from 0- to 1-back, 1- to 2-back and 0- to 2-back. Note: Larger change
score indicates a greater decrease in accuracy as the condition increased in difficulty because performance is expected to be worse as the more demanding condition
(ie, 1-back) relative to the less demanding condition (ie, 0-back). *Val/Val subjects demonstrated a greater change score compared to Met/Met subjects, p  0.05.

deterioration going from 0- to 1-back, while Val/Met subjects
did not differ from the other groups. There were no signiﬁcant
genotype differences in change of performance from 1- to
2-back F(2, 29) = 0.12, p = 0.89, or 0- to 2-back, F(2, 29) =
2.04, p = 0.15, although the Val/Val group clearly showed
the largest deterioration from 0 to 2 back.

Effects of COMT genotype on other
PFC indices
A series of ANOVAs were conducted to examine genotype
group differences on processing speed, as indexed by Trails
Making A and B, and verbal working memory, as indexed
by the PASAT. One subject from the Val/Met genotype had
missing data on these measures and was not included in these
analyses. The genotypes did not differ on Trail Making part
A, F(2, 28) = 3.32, p = 0.51, Trail Making part B, F(2, 28) =
2.24, p = 0.13, or the PASAT, F(2, 28) = 0.29, p = 0.75.

Discussion
The goal of the current study was to examine the effects
of COMT genotype on context processing, as well as to
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replicate previous ﬁndings of working memory deﬁcit in
carriers of the Val allele. We predicted that the Val/Met and
Val/Val genotypes would demonstrate impairment in context
processing, and that this impairment would not be found in
the Met/Met group.
In the modiﬁed AX-CPT context processing is best
understood by the pattern of errors, rather than the overall
number of errors, that an individual makes. Speciﬁcally,
a greater number of AY errors suggest development of
a response bias reﬂecting intact context processing and
individuals with intact context processing tend to make a
smaller number of BX errors. Impaired context processing, on the other hand, is indicated by the reverse pattern:
greater numbers of BX and smaller numbers of AY errors.
While we did not ﬁnd a main effect of genotype, there was
a non-signiﬁcant trend for a genotype by condition interaction. This is likely due to the low statistical power as a result
of the small sample size because additional post-hoc tests
showed that, during both the short and long delays of the
AX-CPT, participants in the Met/Met group demonstrated a
greater number of AY errors, as compared to the other two
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groups. Further, COMT genotype accounted for 20%–21%
of variance in AX-CPT performance which is substantial
compared to previous results of shared variance with other
cognitive tests (Egan et al 2001; Malhotra et al 2002). There
were, however, no differences in the number of BX errors in
either the short or long delay condition, which is interesting
in the context of the recent results of McClure et al (2006). In
that study we found that the beneﬁcial effects of guanfacine,
an adrenergic agonist, were greater on AY than BX errors.
In a study examining executive functioning and COMT,
Egan et al (2001) reported that COMT genotype accounted
for 4% of the variance in frequency of preseverative errors
on the WCST, while the current study found that COMT
genotype accounted for about 20% of the variance on the
AX-CPT. This ﬁnding is quite robust and is consistent with
our hypothesis that the AX-CPT is dopaminergic task that
is sensitive to the effects of COMT. In support of the idea
that the small sample that we collected is still representative,
the Met/Met group in our sample demonstrated an average
of AY error rate of 18.3%, which is similar, albeit slightly
larger, to the rates reported by McDonald et al (2003) and
Barch et al (2001), Thus, the larger variance accounted for
statistics may truly reﬂect differences in task sensitivity to
dopaminergic effects.
Although we did not ﬁnd genotype differences in performance on the N-back working memory test when accuracy
scores were analyzed at each condition of the test, Val/Val
subjects demonstrated a larger change score from 0-back to 1back, as compared to the Met/Met group. Since performance
is expected to be worse at the more difﬁcult condition (ie,
1-back) relative to the less demanding condition (ie, 0-back),
this larger change score demonstrated by the Val/Val indicates a greater decrease in accuracy from a less demanding
condition to a more demanding condition. As such, the
Val/Val subjects performed disproportionately worse as they
progressed from 0-back to 1-back compared to the Met/Met
group. Therefore, ﬁndings of a larger change in performance
0-back to 1-back in the Val/Val group provides evidence of
working memory deﬁcits in those individuals, which is in line
with previous ﬁndings (Goldberg et al 2003). We propose
that this method of examining working memory measured
by the N-back may be of particular utility in future studies.
In contrast, there was no signiﬁcant genotype difference for
the change score from 0-back to 2-back, suggesting that the
difﬁculty level in the 2-back condition may be too high for
all participants and thus resulted in reduced sensitivity.
We predicted that the AX-CPT would be a more sensitive task to detect effects of COMT in comparison to the
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N-back working memory task. COMT genotype explained
comparable amounts of variance in both tasks (20%), but
only with a different analytic plan than previously employed.
Consistent with our hypothesis, processing speed and verbal
working memory were not associated to the effects of COMT
genotype.
A reformulation of the COMT genotype effect on cognition was recently provided by Bilder et al (2004), which suggested that the functional effects of the COMT polymorphism
may be better understood from the perspective of the tonicphasic DA theory. Bilder et al (2004) hypothesized that the
Met allele is associated with increased tonic and decreased
phasic DA transmission, leading to increased stability but
reduced ﬂexibility of neural network activation states that are
central to aspects of working memory. It was suggested that
these effects may be beneﬁcial or detrimental depending the
phenotype and environmental demands (ie, cognitive task).
Thus, given our ﬁndings, the AX-CPT and N-back may be
DA-dependent tasks that require the stability of networks
that underlies working memory, rather than the ﬂexibility
of neural programming.
One major limitation of the current study relates to the
small sample size. However, it should be noted that large
effect sizes were found despite the small number of subjects.
Future studies with a larger sample are needed to replicate
the current ﬁndings. Further, examination of diagnosis ×
genotype interactions would be of interest as well.
One interesting empirical question that the current ﬁndings point to is whether or not COMT genotype plays a
signiﬁcant role in functional disability among patients with
schizophrenia and schizotypal personality disorder. There is a
substantial amount of evidence that schizophrenia is marked
by profound functional impairments, including occupational
(Carpenter and Strauss 1991; McGurk and Meltzer 2000)
and social functioning (Mueser et al 1991; Green 1996;
Green et al 2000). Further, across multiple studies, cognitive
impairment has been found to be consistently related to work
outcomes (Bryson et al 1998; McGurk and Meltzer 2000;
Suslow et al 2000; Tsang et al 2000; Mueser et al 2001)
and cognitive functioning uniquely predicted functional
outcomes in patients (Green 1996) and individuals at risk for
schizophrenia (Niendam et al 2006) over and above clinical symptoms. Thus, it would be interesting to investigate
whether COMT genotype mediates the relationship between
cognitive deﬁcits and functional disability in patients with
schizophrenia and schizotypal personality disorder.
In summary, preliminary results of the current study provided some evidence that context processing and working
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memory are associated with COMT genotype variation,
and the AX-CPT and N-back are two theoretically dopaminergic dependent tasks most sensitive in capturing the
effects of COMT. Processing speed and verbal working
memory were not found to be related to COMT genotype
in the current sample. Taken together, this study provides
evidence that variation in COMT genotype does not lead
to general impairment of cognitive functioning, but that it
uniquely affects two speciﬁc prefrontal domains, context
processing and working memory.
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